Issue |
Section |
Title |
File |
Vol 19, No 3 (2020) |
CLINICAL OBSERVATIONS |
Therapy-related acute myeloid leukemia in a patient with neuroblastoma: case report |
 (Rus)
|
Vol 19, No 3 (2020) |
LITERATURE REVIEW |
Anti-GD2 immunotherapy with the chimeric antibody ch14.18 for high-risk neuroblastoma |
 (Rus)
|
Vol 19, No 4 (2020) |
ПЕРЕДОВАЯ СТАТЬЯ |
Pharmacokinetics of 13-cis-Retinoic acid in high-risk neuroblastoma patients |
 (Rus)
|
Vol 20, No 4 (2021) |
ORIGINAL ARTICLES |
Clear cell sarcoma of the kidney in children: clinical characteristics and treatment results |
 (Rus)
|
Vol 21, No 4 (2022) |
CLINICAL OBSERVATIONS |
Long-term musculoskeletal side effects in patients with neuroblastoma who have completed specific therapy (case reports and literature review) |
 (Rus)
|
Vol 22, No 4 (2023) |
ORIGINAL ARTICLES |
Angiosarcoma in children: the experience of the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology and literature review |
 (Rus)
|
Vol 22, No 4 (2023) |
ORIGINAL ARTICLES |
Bilateral pheochromocytoma in patients with von Hippel–Lindau syndrome: clinical and molecular genetic features |
 (Rus)
|
Vol 23, No 1 (2024) |
ORIGINAL ARTICLES |
Tolerability and toxicity of induction chemoimmunotherapy with dinutuximab beta in newly diagnosed patients with high-risk neuroblastoma |
 (Rus)
|
Vol 23, No 3 (2024) |
ORIGINAL ARTICLES |
Second malignant neoplasms after neuroblastoma treatment: a single center experience |
 (Rus)
|